Investments
27Portfolio Exits
9Funds
2
Want to inform investors similar to LifeSci Venture Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest LifeSci Venture Partners News
May 11, 2022
The financing round saw participation from other new investors Pavilion Capital, Section 32, Invus and LifeSci Venture Partners. All of the Series A investors of Moma including Third The post Moma Therapeutics completes funding for precision oncology programmes appeared first on Pharmaceutical Business review.
LifeSci Venture Partners Investments
27 Investments
LifeSci Venture Partners has made 27 investments. Their latest investment was in MOMA Therapeutics as part of their Series B on May 5, 2022.
LifeSci Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/10/2022 | Series B | MOMA Therapeutics | $150M | Yes | 7 | |
2/18/2022 | Series C | Beta Bionics | $57M | No | 4 | |
1/19/2022 | Series A | Ceptur Therapeutics | $75M | Yes | 5 | |
11/16/2021 | Unattributed VC | |||||
11/3/2021 | Series A |
Date | 5/10/2022 | 2/18/2022 | 1/19/2022 | 11/16/2021 | 11/3/2021 |
|---|---|---|---|---|---|
Round | Series B | Series C | Series A | Unattributed VC | Series A |
Company | MOMA Therapeutics | Beta Bionics | Ceptur Therapeutics | ||
Amount | $150M | $57M | $75M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 7 | 4 | 5 |
LifeSci Venture Partners Portfolio Exits
9 Portfolio Exits
LifeSci Venture Partners has 9 portfolio exits. Their latest portfolio exit was Pyxis Oncology on October 08, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/8/2021 | IPO | Public | 9 | ||
Date | 10/8/2021 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 9 |
LifeSci Venture Partners Fund History
2 Fund Histories
LifeSci Venture Partners has 2 funds, including LifeSci Venture Partners II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/12/2020 | LifeSci Venture Partners II | Early-Stage Venture Capital | Open | $22.99M | 1 |
3/15/2018 | LifeSci Venture Partners I LP |
Closing Date | 2/12/2020 | 3/15/2018 |
|---|---|---|
Fund | LifeSci Venture Partners II | LifeSci Venture Partners I LP |
Fund Type | Early-Stage Venture Capital | |
Status | Open | |
Amount | $22.99M | |
Sources | 1 |
LifeSci Venture Partners Team
3 Team Members
LifeSci Venture Partners has 3 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Paul Yook | Goldman Sachs, and UBS | Founder | Current |
Name | Paul Yook | ||
|---|---|---|---|
Work History | Goldman Sachs, and UBS | ||
Title | Founder | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.